Related Experiment Video
Updated: Jun 25, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Comparison of an expert system with other clinical scores for the evaluation of severity of asthma
V Gautier1, H Rédier, J L Pujol
1Service des Maladies Respiratoires, CJF INSERM, Hôpital universitaire Arnaud de Villeneuve, Montpellier, France.
This study evaluates a new computer-based tool called the Artificial Intelligence (AI) score for assessing asthma severity. Researchers compared this tool against three traditional clinical scoring systems using data from 100 new patients. The findings suggest the AI score identifies higher levels of severity compared to existing methods and correlates well with lung function tests. This tool may offer a practical way for clinicians to standardize severity assessments during initial patient visits.
Area of Science:
- Clinical informatics and Asthmaexpert evaluation within respiratory medicine
- Artificial intelligence applications in chronic disease management
Background:
Clinical practitioners often struggle to standardize the assessment of disease severity in patients presenting with respiratory distress. Prior research has shown that subjective evaluations by individual physicians can lead to inconsistent treatment plans. No prior work had resolved the variability inherent in traditional scoring systems used for chronic airway conditions. That uncertainty drove the development of specialized computational tools to mimic expert decision-making processes. It was already known that existing metrics might not capture the full spectrum of patient health status. This gap motivated the creation of a digital platform designed to mirror the logic of experienced medical specialists. Researchers sought to determine if automated logic could provide more consistent insights than established manual protocols. The current landscape lacks a unified approach for classifying patients during their initial clinical encounters.
Purpose Of The Study:
The aim of this research was to evaluate the performance of a new automated score for assessing disease severity in patients. Researchers sought to understand the medical decision-making processes employed by experts during the management of chronic airway conditions. This investigation addressed the need for more consistent classification methods in outpatient clinical settings. The study specifically examined how a novel computational tool compares to established manual scoring systems. Motivation for this work stemmed from the desire to improve the accuracy of initial patient evaluations. By comparing the automated output with traditional metrics, the authors intended to highlight potential improvements in diagnostic consistency. The project also explored the relationship between the new score and objective functional parameters. This effort provides insight into whether digital tools can effectively supplement or refine existing clinical practices.
Main Methods:
Review approach involved a prospective study design enrolling 100 individuals during their initial outpatient clinic visit. Investigators compared the novel automated metric against three established manual scoring systems. The team utilized the Aas, Hargreave, and Brooks protocols as comparative benchmarks for severity classification. Statistical analysis relied on Kappa and MacNemar tests to determine inter-score reliability. Researchers also performed correlation analyses between the new automated output and objective lung function metrics. The study focused on capturing the decision-making logic of experienced medical professionals through the digital platform. Data collection occurred systematically to ensure consistent input for all evaluated scoring models. This methodological framework allowed for a direct comparison between computational logic and traditional clinical assessment strategies.
Main Results:
Key findings from the literature indicate that the automated system consistently identifies higher levels of severity than the three comparative manual scores. Statistical testing revealed significant differences in classification across all cases using the MacNemar approach. Reliability metrics showed low agreement, with Kappa values of 18%, 28%, and 10% for the Aas, Hargreave, and Brooks systems respectively. The automated score demonstrated a significant positive correlation with forced expiratory volume in one second, yielding an r-value of 0.73. These results suggest that the digital tool provides a more sensitive assessment of patient condition. The data highlight a clear divergence between the automated logic and traditional manual scoring methods. Objective lung function measurements confirmed the clinical relevance of the higher severity ratings assigned by the software. The findings establish that the tool effectively integrates functional parameters into its overall severity determination.
Conclusions:
The authors propose that their automated tool provides a distinct perspective on patient status compared to traditional metrics. Synthesis and implications suggest that this digital approach identifies more severe cases than established manual scoring systems. The researchers indicate that the system demonstrates strong alignment with objective lung function measurements. These findings imply that the tool serves as a practical resource for clinicians during initial patient assessments. The authors note that the observed differences in severity classification highlight the unique logic embedded within the software. The study suggests that adopting such computational aids could improve the consistency of initial diagnostic evaluations. The researchers conclude that the system is straightforward to implement in busy outpatient settings. The evidence supports the utility of this approach for enhancing clinical decision-making processes in respiratory care.
Frequently Asked Questions
The researchers propose that the AI score functions by mimicking expert medical logic to classify patient status. This tool identified higher severity levels compared to the Aas, Hargreave, and Brooks systems, showing significant differences via MacNemar testing.
The study utilized the Asthmaexpert platform to generate the AI score. This software was developed specifically to capture the decision-making patterns of experienced clinicians when managing individuals with chronic airway obstruction.
The authors state that the AI score requires data from the first consultation. This timing is necessary because the tool aims to provide an immediate, standardized classification for new patients entering the outpatient clinic environment.
The researchers employed forced expiratory volume in one second (FEV1) as a functional parameter. This data type served as an objective benchmark to validate the accuracy of the automated severity classification system.
The team measured the reliability between systems using Kappa and MacNemar tests. These statistical methods revealed low agreement, with Kappa values of 18%, 28%, and 10% when compared against the Aas, Hargreave, and Brooks scores respectively.
The authors propose that this tool is easy to use for initial patient visits. They suggest that its integration could assist practitioners in obtaining a more comprehensive understanding of disease severity during the first encounter.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations

